Navigation Links
Bird Flu Vaccine Trials In Australia

A vaccine, to prevent the attack of the deadly bird flu virus, will be tested on Australians in bigger doses, after the initial trial reports announce it safe and effective//.

A trial of the human vaccine, developed by Melbourne pharmaceutical manufacturer, CSL, against the lethal H5N1 virus, have begun by the scientists in Perth. The vaccine could prove a powerful weapon in the fight against bird flu and is the only one of its kind, being developed in the southern hemisphere.

. Initial tests, conducted by Melbourne researchers, found the vaccine to be effective with little side effects.

Study leader Dr Peter Richmond said: "In the initial trial a small dose of the vaccine generated a good immune response in about half the participants,”

"In this trial we will increase the dosage to see if it promotes good immunity in a larger proportion of participants," he added.

"Even with the increase, the total amount of vaccine is still the same as what would be found in conventional flu vaccines."

He said volunteers would receive two doses of the vaccine, in a gap of three weeks. "They will then have blood tests over the following year to check their immunity."

“If results were positive, stocks would then be manufactured to have on hand to protect against a possible bird flu pandemic” Dr Richmond said.

"While there hasn't been any case of bird flu being spread from human to human, it's important that we're not complacent and (we'll) keep working to find ways to protect our community from a possible pandemic," he said.

"The best preparation is to have a vaccine available that is proven to be safe and effective - and that's our aim." he said.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/24/2017)... Raton (PRWEB) , ... August 24, 2017 , ... ... dietary supplements that help people improve all aspects of their health and wellness, ... States. , The step represents a component of Natural Subsistence’s aggressive marketing strategy ...
(Date:8/24/2017)... ... August 24, 2017 , ... Indosoft Inc. announces the ... of contact center application development experience. It represents a complete redesign of ... Indosoft designed Q-Suite NG for simple integration. A full set of APIs allows ...
(Date:8/23/2017)... ... 23, 2017 , ... Jachimowicz Law Group is excited to announce ... 115. The office is located between Schiele and Pershing avenues, with convenient parking for ... can still call the office at 408-246-5500. , Jachimowicz Law Group has ...
(Date:8/23/2017)... ... August 23, 2017 , ... Earlier this month, the Workgroup for Electronic ... IT to create efficiencies in healthcare information exchange and a trusted advisor to the ... which featured keynote addresses by Donald W. Rucker, MD, head of the Office ...
(Date:8/23/2017)... ... 2017 , ... Nightingale College continues the semiannual Give Back Day tradition for ... College dedicates to serving and volunteering for organizations that provide indispensable resources to the ... that need a little extra help. , The College’s Give Back Day initiative ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology: